Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03301792 · ClinicalTrials.gov registry record · NA

Group Versus Traditional Prenatal Care for Diabetes

A NA study of Type 2 Diabetes and Pregnancy, sponsored by Washington University School of Medicine.

Active
Registry status
NA
Development phase
117
Enrollment target
2
Study locations

NCT03301792: Active NA study of Type 2 Diabetes and Pregnancy, sponsored by Washington University School of Medicine.

NCT03301792 is a NA study of Type 2 Diabetes and Pregnancy that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 117 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03301792, a NA study of Type 2 Diabetes and Pregnancy, is active but no longer recruiting, sponsored by Washington University School of Medicine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
117 participants
Enrollment target
2
Study locations

Study Summary

The investigators primary objective is to conduct a randomized trial to determine the effect of diabetes group prenatal care on glycemic control and postpartum weight retention in women with type 2 diabetes and gestational diabetes.

Primary Outcome

Determine the effect of Diabetes Group care on maternal glycemic control by randomizing women to Diabetes group care or traditional care and compare 1) Mean fasting blood glucose, 2) Mean 1-hour post-prandial blood glucose, and 3) Hemoglobin A1c at delivery, 4-12 weeks postpartum, six months postpartum, one year postpartum

Interventions

  • BEHAVIORAL Group prenatal care

Study Locations (2)

Missouri

  • Washington University in St. Louis - St Louis

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2017-09-14
Est. Completion 2026-05
Phase NA

What the registry record for NCT03301792 still lists

NCT03301792 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).

The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Group prenatal care is the first listed.

NCT03301792 reports a single indexed study location in Missouri, Utah.

Frequently Asked Questions

What is clinical trial NCT03301792 about?

NCT03301792 is a clinical study titled "Group Versus Traditional Prenatal Care for Diabetes". The investigators primary objective is to conduct a randomized trial to determine the effect of diabetes group prenatal care on glycemic control and postpartum weight retention in women with type 2 diabetes and gestational diabetes.

What is the current status of trial NCT03301792?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2017-09-14. Estimated completion is 2026-05.

What conditions does trial NCT03301792 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Pregnancy, Gestational Diabetes.

What interventions are being tested in trial NCT03301792?

The interventions under investigation include: Group prenatal care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03301792?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03301792 being conducted?

This trial has 2 study locations across Missouri, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03301792's enrollment target sits among peer trials

117 136th of 327 higher than 191 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03301792, the US trial registry maintained by the National Library of Medicine. NCT03301792 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.